Look at STXS in the last few days, this could happen to MEDS, Medistem has out about Twice the shares as STXS and Medistem has 1000 times more potential in the stem cell industry than STXS catheter system, MEDS could easily hit $25.00 short term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.